Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Is An Independent Factor for Poor Prognosis in Gastric Cancer Associated with Enhanced Cancer Cell Proliferation

被引：0
|
作者：
Tatsuwaki, Hiroshi
Tanigawa, Tetsuya
Watanabe, Toshio
Machida, Hirohisa
Okazaki, Hirotoshi
Yamagami, Hirokazu
Shiba, Masatsugu
Watanabe, Kenji
Tominaga, Kazunari
Fujiwara, Yasuhiro
Oshitani, Nobuhide
Muguruma, Kazuya
Sawada, Tetsuji
Hirakawa, Kosei
Higuchi, Kazuhide
Arakawa, Tetsuo
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A744 / A744
页数：1
相关论文
共 50 条
  • [21] 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells
    Lehtinen, Laura
    Vainio, Paula
    Wikman, Harriet
    Reemts, Johannes
    Hilvo, Mika
    Issa, Rana
    Pollari, Sirkku
    Brandt, Burkhard
    Oresic, Matej
    Pantel, Klaus
    Kallioniemi, Olli
    Iljin, Kristiina
    JOURNAL OF PATHOLOGY, 2012, 226 (04): : 674 - 686
  • [22] Focusing Downstream in Lung Cancer Prevention: 15-Hydroxyprostaglandin Dehydrogenase
    Dubinett, Steven M.
    Mao, Jenny T.
    Hazra, Saswati
    CANCER PREVENTION RESEARCH, 2008, 1 (04) : 223 - 225
  • [23] CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis
    Cao, Yi
    Xiong, Jianbo
    Li, Zhengrong
    Zhang, Guoyang
    Tu, Yi
    Wang, Lizhen
    Jie, Zhigang
    MOLECULAR MEDICINE REPORTS, 2019, 20 (04) : 3661 - 3670
  • [24] 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy
    Na, Hye-Kyung
    Park, Jong-Min
    Lee, Hee Geum
    Lee, Ha-Na
    Myung, Seung-Jae
    Surh, Young-Joon
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1352 - 1360
  • [25] Downregulation of 15-hydroxyprostaglandin dehydrogenase in hormone-resistant breast cancer
    Cummings, M.
    Maraqa, L.
    Peter, M. B.
    Shaaban, A. M.
    Hanby, A. M.
    Hull, M. A.
    Speirs, V.
    BREAST CANCER RESEARCH, 2008, 10 : S17 - S17
  • [26] Downregulation of 15-hydroxyprostaglandin dehydrogenase in hormone-resistant breast cancer
    M Cummings
    L Maraqa
    MB Peter
    AM Shaaban
    AM Hanby
    MA Hull
    V Speirs
    Breast Cancer Research, 10
  • [27] 15-hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3β and a tumor suppressor in lung cancer
    Huang, Guosheng
    Eisenberg, Rosana
    Yan, Min
    Monti, Stefano
    Lawrence, Earl
    Fu, Pingfu
    Walbroehl, Jaclyn
    Loewenberg, Ester
    Golub, Todd
    Merchan, Jaime
    Tenen, Daniel G.
    Markowitz, Sanford D.
    Halmos, Balazs
    CANCER RESEARCH, 2008, 68 (13) : 5040 - 5048
  • [28] Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
    Kaliberova, Lyudmila N.
    Kusmartsev, Sergei A.
    Krendelchtchikova, Valentina
    Stockard, Cecil R.
    Grizzle, William E.
    Buchsbaum, Donald J.
    Kaliberov, Sergey A.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (11) : 3130 - 3139
  • [29] MicroRNA-21 induces loss of 15-hydroxyprostaglandin dehydrogenase in early gastric tubular adenocarcinoma
    Young Soo Park
    Jeong Hoon Lee
    Deok-Beom Jung
    Han-Byul Kim
    Jin-Hak Jung
    Sehyung Pak
    Yeon-Mi Ryu
    Hye Jin Park
    Yun-Yong Park
    Hwoon-Yong Jung
    Seung-Jae Myung
    Scientific Reports, 8
  • [30] MicroRNA-21 induces loss of 15-hydroxyprostaglandin dehydrogenase in early gastric tubular adenocarcinoma
    Park, Young Soo
    Lee, Jeong Hoon
    Jung, Deok-Beom
    Kim, Han-Byul
    Jung, Jin-Hak
    Pak, Sehyung
    Ryu, Yeon-Mi
    Park, Hye Jin
    Park, Yun-Yong
    Jung, Hwoon-Yong
    Myung, Seung-Jae
    SCIENTIFIC REPORTS, 2018, 8
12345